Background: A coronavirus disease 2019 (COVID-19) outbreak led to a worldwide
pandemic. COVID-19 not only caused acute symptoms during the severe phase of the …

Objective While several laboratory variables have been used to assess COVID-19 disease,
to our knowledge, no attempt has previously been made to compare differences across …

Background Post-acute coronavirus disease 2019 (COVID-19) syndrome, also known as
long COVID, is a prolonged illness after the acute phase of COVID-19. Hospitalized patients …

The catastrophic coronavirus disease 2019 (COVID-19) pandemic is currently a critical
global issue. One well-known complication of COVID-19 in severe cases is acute kidney …

Background The current coronavirus pandemic (COVID-19) was caused by severe acute
respiratory syndrome virus 2 (SARS-CoV-2). COVID-19 is characterized by atypical …

Background Activation of inflammatory pathways promotes organ dysfunction in COVID-19.
Currently, there are reports describing lung function abnormalities in COVID-19 survivors; …

Background. Since the first reports of severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) infections in December 2019 in Wuhan, China, the virus has spread to other …

In this prospective study, we assessed biomarkers of inflammation (IL-6 and SAA) from the
serum of 120 COVID-19 patients, of whom 70 had chronic kidney disease. All the samples …

Objective: Coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection is a global issue. In addition to managing acute …

BACKGROUND The new coronavirus causes systemic inflammation and damage to various
organs. So, this study aimed to follow up patients with COVID− 19 after recovery for three …